Rabe Gerd W., Heise Henrike, Yap Glenn P. A., Liable-Sands Louise M., Guzei Ilia A., Rheingold Arnold L.
Anorganisch-chemisches Institut, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany, and Department of Chemistry, University of Delaware, Newark, Delaware 19716.
Inorg Chem. 1998 Aug 24;37(17):4235-4245. doi: 10.1021/ic971178y.
The molecular structures of the rubidium and cesium derivatives of supermesitylphosphane [i.e., (2,4,6-(t)Bu(3)C(6)H(2))PH(2) = (t)Bu(3)MesPH(2)] as well as several base adducts of these are reported. Sodium hydride, potassium hydride, rubidium metal, and cesium metal react with (t)Bu(3)MesPH(2) in tetrahydrofuran solution at room temperature to produce MPRH salts 1-4 [M = Na (1), K (2), Rb (3), Cs (4); R = (t)Bu(3)Mes] in good yields. X-ray-quality crystals of 2 and 3 were obtained by slow evaporation of solutions of the corresponding MP(H)(t)Bu(3)Mes species dissolved in toluene/thf. Complex 4 was crystallized from hot toluene. On the other hand, slow evaporation of a toluene/tetrahydrofuran solution of CsP(H)(t)Bu(3)Mes (4) produces crystals of the composition {CsP(H)(t)Bu(3)Mes(&mgr;-THF)(0.9).toluene}(x)() (5). Crystallization of 4 in the presence of pyridine yields crystals of {CsP(H)(t)Bu(3)Mes(&mgr;-pyridine)}(x)() (6). Also, crystallization of complexes 3 and 4 from toluene/N-methylimidazole (N-MeIm) gives the isomorphous complexes {RbP(H)(t)Bu(3)Mes(&mgr;-N-MeIm)}(x)() (7) and {CsP(H)(t)Bu(3)Mes(&mgr;-N-MeIm)}(x)() (8), respectively. However, crystallization of 4 from toluene in the presence of bidentate or polydentate bases such as dimethoxyethane or pentamethyldiethylenetriamine does not result in incorporation of these bases into the lattice. Instead, the toluene solvate {CsP(H)(t)Bu(3)Mes(eta(3)-toluene)(0.5)}(x)() (9) is obtained. On the other hand, crystallization of 4 from toluene/ethylenediamine gives the base adduct {CsP(H)(t)Bu(3)Mes(&mgr;-ethylenediamine)}(x)() (10). Complex 3 crystallizes in the triclinic space group P&onemacr;. Crystal data for 3 at 218 K: a = 6.71320(10) Å, b = 10.5022(2) Å, c = 14.9733(3) Å, alpha = 91.3524(13) degrees, beta = 102.5584(13) degrees, gamma = 107.7966(14) degrees; Z = 1; R(1) = 6.55%. Complex 4 crystallizes in the triclinic space group P&onemacr;. Crystal data for 4 at 223 K: a = 7.0730(14) Å; b = 10.395(2) Å; c = 14.933(2) Å; alpha = 81.97(1) degrees; beta = 76.35(2) degrees; gamma = 71.824(14) degrees; Z = 1; R(1) = 4.56%. Complex 5 crystallizes in the monoclinic space group P2(1)/c. Crystal data for 5 at 243 K: a = 15.039(2) Å; b = 16.152(3) Å; c = 20.967(5) Å; beta = 91.53(2) degrees; Z = 4; R(1) = 4.83%. Complex 6 crystallizes in the orthorhombic space group Pbcn. Crystal data for 6 at 298 K: a = 14.686(2) Å; b = 21.295(5) Å; c = 28.767(5) Å; Z = 8; R(1) = 5.61%. Complex 7 crystallizes in the orthorhombic space group Pbcn. Crystal data for 7 at 218 K: a = 14.5533(2) Å; b = 21.4258(5) Å; c = 28.5990(5) Å; Z = 8; R(1) = 4.61%. Complex 8 crystallizes in the orthorhombic space group Pbcn. Crystal data for 8 at 219 K: a = 14.6162(2) Å; b = 21.3992(3) Å; c = 28.7037(2) Å; Z = 8; R(1) = 3.57%. Complex 9 crystallizes in the triclinic space group P&onemacr;. Crystal data for 9 at 293 K: a = 11.147(4) Å; b = 14.615(4) Å; c = 14.806(5) Å; alpha = 70.57(3) degrees; beta = 71.85(3) degrees; gamma = 72.93(2) degrees; Z = 2; R(1) = 5.13%. Complex 10 crystallizes in the triclinic space group P&onemacr;. Crystal data for 10 at 173 K: a = 10.5690(4) Å; b = 15.0376(5) Å; c = 15.3643(5) Å; alpha = 111.8630(10) degrees; beta = 100.4120(10) degrees; gamma = 97.4820(2) degrees; Z = 2; R(1) = 4.87%. A common feature of the molecular structures of complexes 2-10 is an infinitely extended polymeric ladder framework in the solid state. Both solution and solid-state NMR data are presented.
报道了超均三甲苯基膦[即(2,4,6-(叔丁基)₃C₆H₂)PH₂ = (叔丁基)₃MesPH₂]的铷和铯衍生物以及这些衍生物的几种碱加合物的分子结构。氢化钠、氢化钾、金属铷和金属铯在室温下于四氢呋喃溶液中与(叔丁基)₃MesPH₂反应,以良好的产率生成MPRH盐1 - 4[M = Na (1)、K (2)、Rb (3)、Cs (4);R = (叔丁基)₃Mes]。通过缓慢蒸发溶解在甲苯/四氢呋喃中的相应MP(H)(叔丁基)₃Mes物种的溶液,获得了2和3的X射线质量晶体。配合物4从热甲苯中结晶。另一方面,CsP(H)(叔丁基)₃Mes (4)的甲苯/四氢呋喃溶液缓慢蒸发产生组成为{[CsP(H)(叔丁基)₃Mes]₂(μ - THF)₀.₉·甲苯}ₓ (5)的晶体。在吡啶存在下使4结晶得到{[CsP(H)(叔丁基)₃Mes]₂(μ - 吡啶)}ₓ (6)的晶体。此外,配合物3和4从甲苯/N - 甲基咪唑(N - MeIm)中结晶分别得到同构配合物{[RbP(H)(叔丁基)₃Mes]₂(μ - N - MeIm)}ₓ (7)和{[CsP(H)(叔丁基)₃Mes]₂(μ - N - MeIm)}ₓ (8)。然而,在二齿或多齿碱如二甲氧基乙烷或五甲基二亚乙基三胺存在下使4从甲苯中结晶,不会导致这些碱掺入晶格。相反,得到甲苯溶剂合物{[CsP(H)(叔丁基)₃Mes]₂(η³ - 甲苯)₀.₅}ₓ (9)。另一方面,4从甲苯/乙二胺中结晶得到碱加合物{[CsP(H)(叔丁基)₃Mes]₂(μ - 乙二胺)}ₓ (10)。配合物3结晶于三斜空间群Pī。3在218 K时的晶体数据:a = 6.71320(10) Å,b = 10.5022(2) Å,c = 14.9733(3) Å,α = 91.3524(13)°,β = 102.5584(13)°,γ = 107.7966(14)°;Z = 1;R(1) = 6.55%。配合物4结晶于三斜空间群Pī。4在223 K时的晶体数据:a = 7.0730(14) Å;b = 10.395(2) Å;c = 14.933(2) Å;α = 81.97(1)°;β = 7,6.35(2)°;γ = 71.824(14)°;Z = 1;R(1) = 4.56%。配合物5结晶于单斜空间群P2(1)/c。5在243 K时的晶体数据:a = 15.039(2) Å;b = 16.152(3) Å;c = 20.967(5) Å;β = 91.53(2)°;Z = 4;R(1) = 4.83%。配合物6结晶于正交空间群Pbcn。6在298 K时的晶体数据:a = 14.686(2) Å;b = 21.2,95(5) Å;c = 28,767(5) Å;Z = 8;R(1) = 5.61%。配合物7结晶于正交空间群Pbcn。7在218 K时的晶体数据:a = 14.5533(2) Å;b = 21.4258(5) Å;c = 28.5990(5) Å;Z = 8;R(1) = 4.61%。配合物8结晶于正交空间群Pbcn。8在219 K时的晶体数据:a = 14.6162(,2) Å;b = 21.3992(3) Å;c = 28.7037(2) Å;Z = 8;R(1) = 3.57%。配合物9结晶于三斜空间群Pī。9在293 K时的晶体数据:a = 11.147(4) Å;b = 14.615(4) Å;c = 14.806(5) Å;α = 70.57(3)°;β = 71.85(3)°;γ = 72.93(,2)°;Z = 2;R(1) = 5.13%。配合物10结晶于三斜空间群Pī。10在173 K时的晶体数据:a = 10.5690(4) Å;b = 15.0376(5) Å;c = 15.3643(5) Å;α = 111.8630(10)°;β = 100.4120(10)°;γ = 97.4820(2)°;Z = 2;R(1) = 4.87%。配合物2 - 10分子结构的一个共同特征是在固态下具有无限延伸的聚合物阶梯框架。同时给出了溶液和固态NMR数据。